Fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded sequence and application of fusion protein
2012
The invention relates to a fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded nucleotide sequence and application of the fusion protein in treatment of malignant tumor.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
0
Citations
NaN
KQI